Not Applicable clinical trials

Explore recruiting not applicable clinical trials.

Recruiting not applicable studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Not Applicable trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Not applicable

Belgium

Human Pharmacology (Phase I)- Other EU CTIS Study details

A Long-Term Follow-Up Protocol for Participants Previously Treated with KYV-101 (KYSA-4)

Germany

Phase II and Phase III (Integrated) EU CTIS Study details

A Pilot and Surgical Study of Larotrectinib for Treatment of Children with Newly Diagnosed High-Grade Glioma with NTRK Fusion

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Access to Pirfenidone Solution for Inhalation (AP01) for Treatment of Progressive, Fibrosing Interstitial Lung Diseases, including Idiopathic Pulmonary Fibrosis

Netherlands, Czechia, Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

A Study to Learn How Safe Different Doses of NTS-521 are, What the Amount of NTS-521 in the Body is Over a Period of Time, and What the Effects of NTS-521 on the Body and the Body on NTS-521 are in Adult and Elderly People Receiving Single and Multiple Doses of NTS-521 via an Infusion Directly into a Vein

Belgium

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A Phase 2 Open-label Extension Study for Subjects with Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study

Germany, Spain, Romania, Belgium, Italy, Sweden +9 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Not Applicable trials by city

Not Applicable in Toronto Not Applicable in Vancouver Not Applicable in Montreal Not Applicable in Calgary Not Applicable in Edmonton Not Applicable in Ottawa Not Applicable in Winnipeg Not Applicable in Quebec City Not Applicable in Hamilton Not Applicable in Kitchener Not Applicable in London Not Applicable in Halifax Not Applicable in New York Not Applicable in Los Angeles Not Applicable in Chicago Not Applicable in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease